United Health Products (UEEC) Cash & Equivalents (2016 - 2025)
United Health Products (UEEC) has disclosed Cash & Equivalents for 14 consecutive years, with $18376.0 as the latest value for Q3 2025.
- On a quarterly basis, Cash & Equivalents fell 58.03% to $18376.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $18376.0, a 58.03% decrease, with the full-year FY2024 number at $168883.0, up 76.99% from a year prior.
- Cash & Equivalents was $18376.0 for Q3 2025 at United Health Products, up from $225.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $170588.0 in Q1 2021 to a low of $225.0 in Q2 2025.
- A 5-year average of $62297.1 and a median of $32955.0 in 2022 define the central range for Cash & Equivalents.
- Peak YoY movement for Cash & Equivalents: soared 2188.55% in 2021, then tumbled 98.8% in 2025.
- United Health Products' Cash & Equivalents stood at $21799.0 in 2021, then tumbled by 38.63% to $13377.0 in 2022, then surged by 613.31% to $95420.0 in 2023, then surged by 76.99% to $168883.0 in 2024, then tumbled by 89.12% to $18376.0 in 2025.
- Per Business Quant, the three most recent readings for UEEC's Cash & Equivalents are $18376.0 (Q3 2025), $225.0 (Q2 2025), and $4914.0 (Q1 2025).